All Stories

  1. Questioning the kidney-protective effect of tolvaptan: a biologically plausible hypothesis to revisit the current narrative
  2. Higher circulating FGF21, lower protein intake, and lower muscle mass: Associations with a higher risk of mortality
  3. Deterioration in Renal Function in Patients With a Fontan Circulation and Association With Mortality
  4. Sparsentan and kidney protection: improved medullary oxygenation?
  5. Adapting Clinical and Research Practice to Global Warming
  6. Comment on Zu et al. Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus. Diabetes Care 2024;47:371–378
  7. [99mTc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients
  8. Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients
  9. Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population‐based cohort
  10. Creatine homeostasis and the kidney: comparison between kidney transplant recipients and healthy controls
  11. Potential Mediating Role of Iron Biomarkers in the Association of Sex With Glucose, Insulin, and Type 2 Diabetes
  12. Plasma symmetric dimethylarginine and kidney graft function in kidney transplant recipients
  13. Acoramidis in Transthyretin Amyloid Cardiomyopathy
  14. Evaluating the effect of bempedoic acid on kidney function: call for cautious implementation
  15. Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
  16. Development and External Validation of a Home-based Risk Prediction Model of Natural Onset of Menopause—Teuta
  17. Utility of iron biomarkers in differentiating menopausal status: Findings from CoLaus and PREVEND
  18. Integer Cystatin C Values: Impact on Discordance Group Assignment and Accuracy of GFR-Estimating Equations
  19. Rounding creatinine, cystatin C, or both: impact on discordance group assignment and GFR-estimating equation performance
  20. Tolvaptan, Kidney Function Decline, and Potential Confounding by Muscle Wasting
  21. Changes in Iron Status Biomarkers with Advancing Age According to Sex and Menopause: A Population-Based Study
  22. Comparison of anal function and quality of life after conformal sphincter preservation operation and intersphincteric resection of very low rectal cancer: a multicenter, retrospective, case–control analysis
  23. Transitions across Kidney Disease Stages and Association with New-onset Heart Failure: a Population-Based study of 8569 Individuals and 12.6 Years of Follow-up
  24. Dietary lithium intake, graft failure and mortality in kidney transplant recipients
  25. Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study
  26. Sex and N-terminal pro B-type natriuretic peptide: The potential mediating role of iron biomarkers
  27. Population-Based Limits of Urine Creatinine Excretion
  28. Letter by Groothof et al Regarding Article, “Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial”
  29. Amino Acid Homeostasis and Fatigue in Chronic Hemodialysis Patients
  30. Reply to Janssen et al. Comment on “Kremer et al. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021, 13, 3069”
  31. Muscle mass and estimates of renal function: a longitudinal cohort study
  32. Plasma Thallium Concentration, Kidney Function, Nephrotoxicity and Graft Failure in Kidney Transplant Recipients
  33. Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness: A Randomized, Double‐Blind, Placebo‐Controlled Intervention Trial
  34. Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41
  35. Gait speed reference values in community-dwelling older adults – Cross-sectional analysis from the Rotterdam Study
  36. Ertugliflozin, renoprotection and potential confounding by muscle wasting
  37. Plasma Lead Concentration and Risk of Late Kidney Allograft Failure: Findings From the TransplantLines Biobank and Cohort Studies
  38. Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes
  39. The simple observational critical care studies: estimations by students, nurses, and physicians of in-hospital and 6-month mortality
  40. Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome
  41. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort
  42. Boron Intake and decreased risk of mortality in kidney transplant recipients
  43. Low Circulating Concentrations of Very Long Chain Saturated Fatty Acids Are Associated with High Risk of Mortality in Kidney Transplant Recipients
  44. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies
  45. Plasma creatine concentration is associated with incident hypertension in a cohort enriched for the presence of high urinary albumin concentration: the Prevention of Renal and Vascular Endstage Disease study
  46. Nonalcoholic fatty liver disease, circulating ketone bodies and all‐cause mortality in a general population‐based cohort
  47. Fibroblast growth factor 21 and protein energy wasting in hemodialysis patients
  48. Urinary 3-hydroxyisovaleryl carnitine excretion, protein energy malnutrition and risk of all-cause mortality in kidney transplant recipients: Results from the TransplantLines cohort studies
  49. Creatine homeostasis and protein energy wasting in hemodialysis patients
  50. Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function?
  51. Muscle mass versus body mass index as predictor of adverse outcome
  52. Relationship between body mass index, cardiovascular biomarkers and incident heart failure
  53. Plasma creatine and incident type 2 diabetes in a general population‐based cohort: The PREVEND study
  54. Association of beta‐hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort
  55. Functional vitamin K status and risk of incident chronic kidney disease and microalbuminuria: a prospective general population-based cohort study
  56. Methylmalonic acid, vitamin B12, renal function, and risk of all-cause mortality in the general population: results from the prospective Lifelines-MINUTHE study
  57. Vibration threshold in non-diabetic subjects
  58. Plasma cadmium is associated with increased risk of long-term kidney graft failure
  59. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis
  60. Thyroid function and risk of all-cause and cardiovascular mortality: a prospective population-based cohort study
  61. Sodium–Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?
  62. Bone Mineral Density and Aortic Calcification: Evidence for a Bone-vascular Axis After Kidney Transplantation
  63. Circulating Arsenic is Associated with Long-Term Risk of Graft Failure in Kidney Transplant Recipients: A Prospective Cohort Study
  64. Regression of Bone-Tracer Uptake in Cardiac Transthyretin Amyloidosis
  65. Association of Plasma Concentration of Vitamin B12With All-Cause Mortality in the General Population in the Netherlands
  66. Concentration of Branched-Chain Amino Acids Is a Strong Risk Marker for Incident Hypertension
  67. Plasma Vitamin C and Cancer Mortality in Kidney Transplant Recipients